» Authors » Itsuki Anzai

Itsuki Anzai

Explore the profile of Itsuki Anzai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 193
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimoto A, Koike T, Kuboki Y, Komaba S, Kosono S, Aswathy M, et al.
Angew Chem Int Ed Engl . 2024 Oct; 64(6):e202411760. PMID: 39373347
Heparan sulfate (HS) is ubiquitous on cell surfaces and is used as a receptor by many viruses including SARS-CoV-2. However, increased activity of the inflammatory enzyme heparanase (HPSE), which hydrolyses...
2.
Anzai I, Fujita J, Ono C, Kosaka Y, Miyamoto Y, Shichinohe S, et al.
Microbiol Spectr . 2024 Feb; 12(4):e0365523. PMID: 38415660
Although the global crisis caused by the coronavirus disease 2019 (COVID-19) pandemic is over, the global epidemic of the disease continues. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of...
3.
Dianty R, Hirano J, Anzai I, Kanai Y, Hayashi T, Morimoto M, et al.
Front Microbiol . 2023 Nov; 14:1284274. PMID: 37928667
It is essential to employ efficient measures to prevent the transmission of pathogenic agents during a pandemic. One such method involves using hypochlorous acid (HClO) solution. The oxidative properties of...
4.
Fujita J, Makino F, Asahara H, Moriguchi M, Kumano S, Anzai I, et al.
Sci Rep . 2023 Feb; 13(1):2279. PMID: 36755111
Functionalization of graphene is one of the most important fundamental technologies in a wide variety of fields including industry and biochemistry. We have successfully achieved a novel oxidative modification of...
5.
Otsubo R, Minamitani T, Kobiyama K, Fujita J, Ito T, Ueno S, et al.
Sci Rep . 2022 Nov; 12(1):20120. PMID: 36418391
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Variants of concern (VOCs) such as Delta and Omicron have developed, which continue to spread the pandemic. It...
6.
Yamaguchi K, Anzai I, Maeda R, Moriguchi M, Watanabe T, Imura A, et al.
J Biochem . 2022 Nov; 173(2):115-127. PMID: 36413757
The continuous emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants associated with the adaptive evolution of the virus is prolonging the global coronavirus disease 2019 (COVID-19) pandemic. The modification...
7.
Isaka Y, Yoshiya T, Ono C, Uchiyama A, Hirata H, Hamaguchi S, et al.
Clin Exp Nephrol . 2022 Nov; 27(3):279-287. PMID: 36344716
Background: A certain number of patients with coronavirus disease 2019 (COVID-19), particularly those who test positive for SARS-CoV-2 in the serum, are hospitalized. Further, some even die. We examined the...
8.
Maeda R, Fujita J, Konishi Y, Kazuma Y, Yamazaki H, Anzai I, et al.
Commun Biol . 2022 Jul; 5(1):669. PMID: 35794202
We are amid the historic coronavirus infectious disease 2019 (COVID-19) pandemic. Imbalances in the accessibility of vaccines, medicines, and diagnostics among countries, regions, and populations, and those in war crises,...
9.
Tamura T, Torii S, Kajiwara K, Anzai I, Fujioka Y, Noda K, et al.
PLoS Pathog . 2022 Jun; 18(6):e1010593. PMID: 35658055
Flaviviruses, which are globally distributed and cause a spectrum of potentially severe illnesses, pose a major threat to public health. Although Flaviviridae viruses, including flaviviruses, possess similar genome structures, only...
10.
Koike T, Sugimoto A, Kosono S, Komaba S, Kanno Y, Kitamura T, et al.
RSC Med Chem . 2022 Jan; 12(12):2016-2021. PMID: 35028561
Fucoidan derivatives 10-13, whose basic sugar chains are composed of repeating α(1,4)-linked l-fucopyranosyl residues with different sulfation patterns, were designed and systematically synthesized. A structure-activity relationship (SAR) study examined competitive...